Logo image of GIN.DE

GIVAUDAN-REG (GIN.DE) Stock Fundamental Analysis

FRA:GIN - CH0010645932 - Common Stock

3745 EUR
+76 (+2.07%)
Last: 9/5/2025, 7:00:00 PM
Fundamental Rating

6

GIN gets a fundamental rating of 6 out of 10. The analysis compared the fundamentals against 65 industry peers in the Chemicals industry. GIN has an excellent profitability rating, but there are some minor concerns on its financial health. GIN is valied quite expensively at the moment, while it does show a decent growth rate.


Dividend Valuation Growth Profitability Health

9

1. Profitability

1.1 Basic Checks

In the past year GIN was profitable.
GIN had a positive operating cash flow in the past year.
GIN had positive earnings in each of the past 5 years.
Each year in the past 5 years GIN had a positive operating cash flow.
GIN.DE Yearly Net Income VS EBIT VS OCF VS FCFGIN.DE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B

1.2 Ratios

GIN has a better Return On Assets (9.01%) than 92.65% of its industry peers.
With an excellent Return On Equity value of 23.81%, GIN belongs to the best of the industry, outperforming 97.06% of the companies in the same industry.
With an excellent Return On Invested Capital value of 13.14%, GIN belongs to the best of the industry, outperforming 91.18% of the companies in the same industry.
GIN had an Average Return On Invested Capital over the past 3 years of 11.29%. This is above the industry average of 7.08%.
The last Return On Invested Capital (13.14%) for GIN is above the 3 year average (11.29%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA 9.01%
ROE 23.81%
ROIC 13.14%
ROA(3y)8.16%
ROA(5y)7.72%
ROE(3y)22.13%
ROE(5y)21.72%
ROIC(3y)11.29%
ROIC(5y)10.9%
GIN.DE Yearly ROA, ROE, ROICGIN.DE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5 10 15 20

1.3 Margins

The Profit Margin of GIN (14.71%) is better than 95.59% of its industry peers.
GIN's Profit Margin has improved in the last couple of years.
The Operating Margin of GIN (18.96%) is better than 92.65% of its industry peers.
GIN's Operating Margin has improved in the last couple of years.
With a decent Gross Margin value of 44.13%, GIN is doing good in the industry, outperforming 66.18% of the companies in the same industry.
GIN's Gross Margin has improved in the last couple of years.
Industry RankSector Rank
OM 18.96%
PM (TTM) 14.71%
GM 44.13%
OM growth 3Y4.7%
OM growth 5Y4.36%
PM growth 3Y6.18%
PM growth 5Y5.38%
GM growth 3Y1.09%
GM growth 5Y1.59%
GIN.DE Yearly Profit, Operating, Gross MarginsGIN.DE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10 20 30 40

6

2. Health

2.1 Basic Checks

GIN has a Return on Invested Capital (ROIC), which is well above the Cost of Capital (WACC), which means it is creating value.
The number of shares outstanding for GIN remains at a similar level compared to 1 year ago.
Compared to 5 years ago, GIN has more shares outstanding
Compared to 1 year ago, GIN has an improved debt to assets ratio.
GIN.DE Yearly Shares OutstandingGIN.DE Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2M 4M 6M 8M
GIN.DE Yearly Total Debt VS Total AssetsGIN.DE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B 8B 10B

2.2 Solvency

An Altman-Z score of 4.53 indicates that GIN is not in any danger for bankruptcy at the moment.
The Altman-Z score of GIN (4.53) is better than 85.29% of its industry peers.
The Debt to FCF ratio of GIN is 3.57, which is a good value as it means it would take GIN, 3.57 years of fcf income to pay off all of its debts.
GIN's Debt to FCF ratio of 3.57 is amongst the best of the industry. GIN outperforms 85.29% of its industry peers.
GIN has a Debt/Equity ratio of 0.86. This is a neutral value indicating GIN is somewhat dependend on debt financing.
With a Debt to Equity ratio value of 0.86, GIN is not doing good in the industry: 72.06% of the companies in the same industry are doing better.
Industry RankSector Rank
Debt/Equity 0.86
Debt/FCF 3.57
Altman-Z 4.53
ROIC/WACC2.85
WACC4.61%
GIN.DE Yearly LT Debt VS Equity VS FCFGIN.DE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B 4B

2.3 Liquidity

GIN has a Current Ratio of 1.49. This is a normal value and indicates that GIN is financially healthy and should not expect problems in meeting its short term obligations.
Looking at the Current ratio, with a value of 1.49, GIN is doing worse than 63.24% of the companies in the same industry.
GIN has a Quick Ratio of 1.49. This is a bad value and indicates that GIN is not financially healthy enough and could expect problems in meeting its short term obligations.
GIN's Quick ratio of 0.98 is on the low side compared to the rest of the industry. GIN is outperformed by 60.29% of its industry peers.
The current and quick ratio evaluation for GIN is rather negative, while it does have excellent solvency and profitability. These ratios do not necessarly indicate liquidity issues and need to be evaluated against the specifics of the business.
Industry RankSector Rank
Current Ratio 1.49
Quick Ratio 0.98
GIN.DE Yearly Current Assets VS Current LiabilitesGIN.DE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B 4B

4

3. Growth

3.1 Past

The Earnings Per Share has been growing slightly by 4.21% over the past year.
GIN shows a small growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 6.04% yearly.
The Revenue has been growing slightly by 5.93% in the past year.
The Revenue has been growing slightly by 3.63% on average over the past years.
EPS 1Y (TTM)4.21%
EPS 3Y11.12%
EPS 5Y6.04%
EPS Q2Q%0.69%
Revenue 1Y (TTM)5.93%
Revenue growth 3Y3.51%
Revenue growth 5Y3.63%
Sales Q2Q%3.4%

3.2 Future

GIN is expected to show a small growth in Earnings Per Share. In the coming years, the EPS will grow by 6.01% yearly.
GIN is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 4.97% yearly.
EPS Next Y4.09%
EPS Next 2Y4.24%
EPS Next 3Y5.13%
EPS Next 5Y6.01%
Revenue Next Year2.2%
Revenue Next 2Y3.06%
Revenue Next 3Y3.81%
Revenue Next 5Y4.97%

3.3 Evolution

The EPS growth rate is stable: in the next years the growth will be about the same than in the last years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
GIN.DE Yearly Revenue VS EstimatesGIN.DE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 2B 4B 6B 8B 10B
GIN.DE Yearly EPS VS EstimatesGIN.DE Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 50 100 150

3

4. Valuation

4.1 Price/Earnings Ratio

GIN is valuated quite expensively with a Price/Earnings ratio of 28.15.
GIN's Price/Earnings is on the same level as the industry average.
Compared to an average S&P500 Price/Earnings ratio of 27.06, GIN is valued at the same level.
With a Price/Forward Earnings ratio of 26.00, GIN can be considered very expensive at the moment.
Based on the Price/Forward Earnings ratio, GIN is valued a bit more expensive than 63.24% of the companies in the same industry.
GIN's Price/Forward Earnings ratio indicates a similar valuation than the S&P500 average which is at 22.69.
Industry RankSector Rank
PE 28.15
Fwd PE 26
GIN.DE Price Earnings VS Forward Price EarningsGIN.DE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, GIN is valued a bit more expensive than the industry average as 72.06% of the companies are valued more cheaply.
Compared to the rest of the industry, the Price/Free Cash Flow ratio of GIN indicates a somewhat cheap valuation: GIN is cheaper than 66.18% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF 24.37
EV/EBITDA 20.4
GIN.DE Per share dataGIN.DE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 200 400 600 800

4.3 Compensation for Growth

The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates GIN does not grow enough to justify the current Price/Earnings ratio.
GIN has an outstanding profitability rating, which may justify a higher PE ratio.
PEG (NY)6.88
PEG (5Y)4.66
EPS Next 2Y4.24%
EPS Next 3Y5.13%

4

5. Dividend

5.1 Amount

With a Yearly Dividend Yield of 2.01%, GIN has a reasonable but not impressive dividend return.
GIN's Dividend Yield is comparable with the industry average which is at 3.00.
Compared to an average S&P500 Dividend Yield of 2.45, GIN has a dividend comparable with the average S&P500 company.
Industry RankSector Rank
Dividend Yield 2.01%

5.2 History

The dividend of GIN has a limited annual growth rate of 2.07%.
Dividend Growth(5Y)2.07%
Div Incr Years0
Div Non Decr Years0

5.3 Sustainability

57.52% of the earnings are spent on dividend by GIN. This is a bit on the high side, but may be sustainable.
GIN's earnings are growing more than its dividend. This makes the dividend growth sustainable.
DP57.52%
EPS Next 2Y4.24%
EPS Next 3Y5.13%
GIN.DE Yearly Income VS Free CF VS DividendGIN.DE Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M 1B
GIN.DE Dividend Payout.GIN.DE Dividend Payout, showing the Payout Ratio.GIN.DE Dividend Payout.PayoutRetained Earnings

GIVAUDAN-REG

FRA:GIN (9/5/2025, 7:00:00 PM)

3745

+76 (+2.07%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryChemicals
Earnings (Last)07-22 2025-07-22/bmo
Earnings (Next)10-14 2025-10-14
Inst Owners34.12%
Inst Owner ChangeN/A
Ins Owners12.15%
Ins Owner ChangeN/A
Market Cap34.57B
Analysts68.97
Price Target4290.16 (14.56%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 2.01%
Yearly Dividend72.37
Dividend Growth(5Y)2.07%
DP57.52%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-4.66%
PT rev (3m)-3.7%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)-2.33%
EPS NY rev (3m)-2.33%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)-0.12%
Revenue NY rev (3m)-1.84%
Valuation
Industry RankSector Rank
PE 28.15
Fwd PE 26
P/S 4.38
P/FCF 24.37
P/OCF 19.97
P/B 7.09
P/tB N/A
EV/EBITDA 20.4
EPS(TTM)133.06
EY3.55%
EPS(NY)144.05
Fwd EY3.85%
FCF(TTM)153.69
FCFY4.1%
OCF(TTM)187.49
OCFY5.01%
SpS855.2
BVpS528.21
TBVpS-28.85
PEG (NY)6.88
PEG (5Y)4.66
Profitability
Industry RankSector Rank
ROA 9.01%
ROE 23.81%
ROCE 15.16%
ROIC 13.14%
ROICexc 14.32%
ROICexgc 33.12%
OM 18.96%
PM (TTM) 14.71%
GM 44.13%
FCFM 17.97%
ROA(3y)8.16%
ROA(5y)7.72%
ROE(3y)22.13%
ROE(5y)21.72%
ROIC(3y)11.29%
ROIC(5y)10.9%
ROICexc(3y)12.12%
ROICexc(5y)11.56%
ROICexgc(3y)26.36%
ROICexgc(5y)25.23%
ROCE(3y)13.03%
ROCE(5y)12.58%
ROICexcg growth 3Y11.26%
ROICexcg growth 5Y9.01%
ROICexc growth 3Y9.76%
ROICexc growth 5Y7.13%
OM growth 3Y4.7%
OM growth 5Y4.36%
PM growth 3Y6.18%
PM growth 5Y5.38%
GM growth 3Y1.09%
GM growth 5Y1.59%
F-Score7
Asset Turnover0.61
Health
Industry RankSector Rank
Debt/Equity 0.86
Debt/FCF 3.57
Debt/EBITDA 2.23
Cap/Depr 81.62%
Cap/Sales 3.95%
Interest Coverage 15.27
Cash Conversion 92.12%
Profit Quality 122.2%
Current Ratio 1.49
Quick Ratio 0.98
Altman-Z 4.53
F-Score7
WACC4.61%
ROIC/WACC2.85
Cap/Depr(3y)97.93%
Cap/Depr(5y)83.59%
Cap/Sales(3y)4.95%
Cap/Sales(5y)4.45%
Profit Quality(3y)99.97%
Profit Quality(5y)111.02%
High Growth Momentum
Growth
EPS 1Y (TTM)4.21%
EPS 3Y11.12%
EPS 5Y6.04%
EPS Q2Q%0.69%
EPS Next Y4.09%
EPS Next 2Y4.24%
EPS Next 3Y5.13%
EPS Next 5Y6.01%
Revenue 1Y (TTM)5.93%
Revenue growth 3Y3.51%
Revenue growth 5Y3.63%
Sales Q2Q%3.4%
Revenue Next Year2.2%
Revenue Next 2Y3.06%
Revenue Next 3Y3.81%
Revenue Next 5Y4.97%
EBIT growth 1Y25.45%
EBIT growth 3Y8.37%
EBIT growth 5Y8.14%
EBIT Next Year30.52%
EBIT Next 3Y12.9%
EBIT Next 5Y10.37%
FCF growth 1Y45.57%
FCF growth 3Y8.88%
FCF growth 5Y10.3%
OCF growth 1Y18.35%
OCF growth 3Y8.06%
OCF growth 5Y7.42%